Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

PKC ε increases hair follicle stem cell turnover and may raise skin cancer risk.

Targeting Keratin 17 may help overcome cancer therapy resistance.

The document concludes that ERBB2 mutations are common in extramammary Paget disease and may respond to systemic treatments like cancer immunotherapy.

A chromosomal change may cause ectodermal dysplasia and developmental issues in a child.

K6/ODC transgenic mice are effective for quickly identifying cancer-causing chemicals.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

Mice with human-like EGFR had growth issues, skin defects, heart problems, and unusual bone development.

VEGF helps squamous cell carcinoma grow in ways beyond just blood vessel formation.

IGF2BP3 gene is up-regulated in keloid patients, suggesting potential targets for treatment.

Promising cancer treatments were found, but the manufacturer closed.

WNT10A helps esophageal cancer cells spread and keep renewing themselves.

SPT6 prevents excessive skin inflammation by blocking a feedback loop.

A specific mutation known for causing cancer is also found to cause a skin condition in a young girl.

Genetically engineered mouse models help identify key pathways and targets for melanoma treatment.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Keratins K6 and K16 are expressed more freely in regenerating mouse skin than K1 and K10.

Mutant cells in hair follicles are influenced by their location and interactions with surrounding cells.

XEDAR triggers a specific signaling pathway in cells.

CXCR2 in skin cells promotes tumor growth.

Erlotinib can cause nonscarring hair loss and itchy skin.

Enhancers and super-enhancers are key in controlling specific gene activity and can play a role in cancer development.

Targeting EGFR may help reduce hair loss from chemotherapy.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

A rare genetic mutation in the EGFR gene caused severe skin issues and other health problems in a Slovakian girl, who is now 4 years old and receiving care.

The cancer gene c-Myc increases harmful chemicals that damage DNA and can lead to cancer, but antioxidants can reduce this damage.

Gata6 is important for protecting hair growth cells from DNA damage and keeping normal hair growth.